| Quality by design methodology applied to process optimization and scale up of curcumin nanoemulsions produced by catastrophic phase inversion SKR Adena, M Herneisey, E Pierce, PR Hartmeier, S Adlakha, ... Pharmaceutics 13 (6), 880, 2021 | 18 | 2021 |
| Hydrogel dressings for chronic wound healing in diabetes: beyond hydration PR Hartmeier, NB Pham, KY Velankar, F Issa, N Giannoukakis, WS Meng Journal of pharmaceutics & drug delivery research 10 (1), 1000197, 2020 | 8 | 2020 |
| Immune cells activating biotin-decorated PLGA protein carrier PR Hartmeier, JL Kosanovich, KY Velankar, J Armen-Luke, MA Lipp, ... Molecular pharmaceutics 19 (7), 2638-2650, 2022 | 6 | 2022 |
| Fibril-guided three-dimensional assembly of human fibroblastic reticular cells KY Velankar, W Liu, PR Hartmeier, SR Veleke, GA Reddy, B Clegg, ... ACS Applied Bio Materials 7 (6), 3953-3963, 2024 | 1 | 2024 |
| Lymphatic distribution considerations for subunit vaccine design and development PR Hartmeier, SM Ostrowski, EE Busch, KM Empey, WS Meng Vaccine, 2024 | 1 | 2024 |
| Modeling the kinetics of lymph node retention and exposure of a cargo protein delivered by biotin-functionalized nanoparticles PR Hartmeier, JL Kosanovich, KY Velankar, SM Ostrowski, EE Busch, ... Acta biomaterialia 170, 453-463, 2023 | 1 | 2023 |
| Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2, 3-dihydroimidazo [1, 2-A] pyrazin-8-amine bisemsylate as Syk inhibitors TG Elford, PC Fung, PR Hartmeier, JA Jernelius, H Morrison US Patent 11,384,082, 2022 | 1 | 2022 |
| Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2, 3-dihydroimidazo [1, 2-a] pyrazin-8-amine bis-mesylate as Syk inhibitors TG Elford, PC Fung, PR Hartmeier, JA Jernelius, H Morrison US Patent 12,122,781, 2024 | | 2024 |
| Recrystallization of Adenosine for Localized Drug Delivery KY Velankar, M Mou, PR Hartmeier, B Clegg, ES Gawalt, M Jiang, ... Molecular pharmaceutics 19 (9), 3394-3404, 2022 | | 2022 |
